RenovoRx, Inc. (RNXT) bonds
RNXTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30124% above fair value
$1.04−0.12 (-10.34%)
Close on Nov 13, 2026Market cap $46.93MP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
RenovoRx reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in RenovoRx's 10-K for the period ended Dec 31, 2022
| Issue | Coupon | Carrying value |
|---|---|---|
| Two Thousand And Twenty And Two Thousand And Twenty One Convertible Notes Convertible | 12.50% | $5.30M |
| Two Thousand And Twenty Convertible Notes Convertible | 5.00% | – |
| Two Thousand And Twenty One Convertible Notes Convertible | 46.50% | – |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K.
See a number that looks wrong?